[{"Assets_0_Q3_USD":266456000.0,"CommonStockSharesOutstanding_0_Q3_shares":125023015.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-128391000.0,"NetIncomeLoss_1_Q3_USD":-62138000.0,"NetIncomeLoss_3_Q3_USD":-179700000.0,"StockholdersEquity_0_Q3_USD":223440000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":58305000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":164236000.0,"Ticker":"ACAD","CIK":"1070494","name":"ACADIA PHARMACEUTICALS INC","OfficialName":"ACADIA Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3501345407.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]